FDA's MedWatch Safety Alerts: October 2009

FDA's MedWatch Safety Alerts: October 2009

On this page:

- Recall: Accusure Insulin Syringes
-- Potential Medication Errors with Tamiflu for Oral Suspension
--- Defective Power Cords on Medical Devices
---- Risk of Severe Allergic Reaction to Dexferrum
----- Recall: Philips HeartStart Fr2+ Automated External Defibrillators
------ Beware of Fraudulent H1N1 Flu Products Sold on Internet
------- Changes to Heparin

After the Food and Drug Administration (FDA) approves a product and it is on the market, FDA continues to monitor unexpected and undesirable side effects (adverse events) of that product.

Health care professionals and consumers may report side effects, product quality problems, product use errors, or therapeutic failure with the use of medical products to FDA's MedWatch Adverse Event Reporting program either online, by regular mail, by fax, or by phone.
• Online
• Regular Mail: Use postage-paid, pre-addressed FDA form 3500
• Fax: 1-800-FDA-0178
• Phone: 1-800-332-1088

MedWatch reports can signal a safety problem and lead to an FDA action to protect the public from harm, serious illness, or even death.

Here are a few of the most recent safety alerts prompted by reports received by FDA from health care professionals and their patients.

abrir aquí para acceder a las secciones del documento FDA:
FDA's MedWatch Safety Alerts: October 2009